GB202304356D0 - Peptides and uses thereof - Google Patents

Peptides and uses thereof

Info

Publication number
GB202304356D0
GB202304356D0 GBGB2304356.5A GB202304356A GB202304356D0 GB 202304356 D0 GB202304356 D0 GB 202304356D0 GB 202304356 A GB202304356 A GB 202304356A GB 202304356 D0 GB202304356 D0 GB 202304356D0
Authority
GB
United Kingdom
Prior art keywords
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2304356.5A
Other versions
GB2628421A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntherix Limied
Original Assignee
Syntherix Limied
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntherix Limied filed Critical Syntherix Limied
Priority to GB2304356.5A priority Critical patent/GB2628421A/en
Publication of GB202304356D0 publication Critical patent/GB202304356D0/en
Priority to PCT/EP2024/057770 priority patent/WO2024200264A1/en
Publication of GB2628421A publication Critical patent/GB2628421A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/11—Protein-serine/threonine kinases (2.7.11)
    • C12Y207/11022—Cyclin-dependent kinase (2.7.11.22)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB2304356.5A 2023-03-24 2023-03-24 Peptides and uses thereof Pending GB2628421A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB2304356.5A GB2628421A (en) 2023-03-24 2023-03-24 Peptides and uses thereof
PCT/EP2024/057770 WO2024200264A1 (en) 2023-03-24 2024-03-22 Peptides and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2304356.5A GB2628421A (en) 2023-03-24 2023-03-24 Peptides and uses thereof

Publications (2)

Publication Number Publication Date
GB202304356D0 true GB202304356D0 (en) 2023-05-10
GB2628421A GB2628421A (en) 2024-09-25

Family

ID=86228154

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2304356.5A Pending GB2628421A (en) 2023-03-24 2023-03-24 Peptides and uses thereof

Country Status (2)

Country Link
GB (1) GB2628421A (en)
WO (1) WO2024200264A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0804496D0 (en) 2008-03-11 2008-04-16 Theryte Ltd Treating cancer
GB2530479A (en) 2014-08-06 2016-03-30 Hilmar Meek Warenius Peptides useful for treating cancer
CN109922818B (en) * 2016-09-06 2024-02-20 主线生物科学公司 CXCR4 antagonists and methods of use
GB201810923D0 (en) 2018-07-03 2018-08-15 Blueberry Therapeutics Ltd Compositions and method of treatment
GB2582571B (en) * 2019-03-25 2024-02-28 Syntherix Ltd Peptides and use thereof
WO2022144886A1 (en) * 2020-12-30 2022-07-07 Biolinerx Ltd. Process for manufacturing peptide
EP4294820A1 (en) * 2021-02-22 2023-12-27 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with three or more hydrophobic residues
WO2022271818A1 (en) * 2021-06-23 2022-12-29 Entrada Therapeutics, Inc. Antisense compounds and methods for targeting cug repeats

Also Published As

Publication number Publication date
GB2628421A (en) 2024-09-25
WO2024200264A1 (en) 2024-10-03

Similar Documents

Publication Publication Date Title
IL305809A (en) Tumor neoantigenic peptides and uses thereof
IL299907A (en) Stapled peptides and methods thereof
IL308790A (en) Stapled peptides and methods thereof
GB202109082D0 (en) Polypeptides and uses thereof
EP4168028A4 (en) Sars-cov-2 immunodominant peptides and uses thereof
EP4172173A4 (en) Neutrophil-binding peptides
EP3947418C0 (en) Peptides and use thereof
EP4175970A4 (en) Peptides and uses thereof
AU2020234373A1 (en) Novel peptide and use thereof
IL311185A (en) Mog-binding proteins and uses thereof
GB201904720D0 (en) Peptide synthesis and modification
GB202304356D0 (en) Peptides and uses thereof
EP3996737A4 (en) Peptides and uses thereof
EP3984595A4 (en) Peptide and use thereof
GB202100996D0 (en) Ezrin-derived peptides and uses
GB202016456D0 (en) Novel bioactive peptide combinations and uses thereof
AU2021903722A0 (en) Peptides and Uses Thereof
AU2020904544A0 (en) Peptides and uses thereof
AU2020904375A0 (en) Peptides and uses thereof
AU2020902233A0 (en) Peptides and uses thereof
IL284666A (en) Novel peptides and uses thereof
IL308123A (en) Mertk peptides and uses thereof
IL307668A (en) Procoagulant peptides and use thereof
GB202018733D0 (en) Polypeptides and uses thereof
IL309196A (en) Ghr-binding pending peptide and composition comprising same